Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has been increasing by 0.5% per year in the United States. PDAC portends a dismal prognosis and novel therapies are needed. This study describes the generation and characterization of a novel oncolytic chimeric orthopoxvirus for the treatment of pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: O’Leary, Michael P., Choi, Audrey H., Kim, Sang-In, Chaurasiya, Shyambabu, Lu, Jianming, Park, Anthony K., Woo, Yanghee, Warner, Susanne G., Fong, Yuman, Chen, Nanhai G.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5918769/
https://ncbi.nlm.nih.gov/pubmed/29699566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1483-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados